IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v40y2020i4p474-482.html
   My bibliography  Save this article

The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology

Author

Listed:
  • Inge M. C. M. de Kok

    (Department of Public Health, Erasmus MC—University Medical Center, Rotterdam, Zuid-Holland, The Netherlands)

  • Emily A. Burger

    (Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA)

  • Steffie K. Naber

    (Department of Public Health, Erasmus MC—University Medical Center, Rotterdam, Zuid-Holland, The Netherlands)

  • Karen Canfell

    (Cancer Research Division, Cancer Council NSW, Sydney, Australia
    School of Public Health, University of Sydney, Sydney, Australia
    Prince of Wales Clinical School, University of New South Wales, Sydney, Australia)

  • James Killen

    (Cancer Research Division, Cancer Council NSW, Sydney, Australia)

  • Kate Simms

    (Cancer Research Division, Cancer Council NSW, Sydney, Australia)

  • Shalini Kulasingam

    (School of Public Health, University of Minnesota, Minneapolis, MN, USA)

  • Emily Groene

    (School of Public Health, University of Minnesota, Minneapolis, MN, USA)

  • Stephen Sy

    (Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA)

  • Jane J. Kim

    (Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA)

  • Marjolein van Ballegooijen

    (Department of Public Health, Erasmus MC—University Medical Center, Rotterdam, Zuid-Holland, The Netherlands)

Abstract

Background . To interpret cervical cancer screening model results, we need to understand the influence of model structure and assumptions on cancer incidence and mortality predictions. Cervical cancer cases and deaths following screening can be attributed to 1) (precancerous or cancerous) disease that occurred after screening, 2) disease that was present but not screen detected, or 3) disease that was screen detected but not successfully treated. We examined the relative contributions of each of these using 4 Cancer Intervention and Surveillance Modeling Network (CISNET) models. Methods . The maximum clinical incidence reduction (MCLIR) method compares changes in the number of clinically detected cervical cancers and mortality among 4 scenarios: 1) no screening, 2) one-time perfect screening at age 45 that detects all existing disease and delivers perfect (i.e., 100% effective) treatment of all screen-detected disease, 3) one-time realistic-sensitivity cytological screening and perfect treatment of all screen-detected disease, and 4) one-time realistic-sensitivity cytological screening and realistic-effectiveness treatment of all screen-detected disease. Results . Predicted incidence reductions ranged from 55% to 74%, and mortality reduction ranged from 56% to 62% within 15 years of follow-up for scenario 4 across models. The proportion of deaths due to disease not detected by screening differed across the models (21%–35%), as did the failure of treatment (8%–16%) and disease occurring after screening (from 1%–6%). Conclusions . The MCLIR approach aids in the interpretation of variability across model results. We showed that the reasons why screening failed to prevent cancers and deaths differed between the models. This likely reflects uncertainty about unobservable model inputs and structures; the impact of this uncertainty on policy conclusions should be examined via comparing findings from different well-calibrated and validated model platforms.

Suggested Citation

  • Inge M. C. M. de Kok & Emily A. Burger & Steffie K. Naber & Karen Canfell & James Killen & Kate Simms & Shalini Kulasingam & Emily Groene & Stephen Sy & Jane J. Kim & Marjolein van Ballegooijen, 2020. "The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology," Medical Decision Making, , vol. 40(4), pages 474-482, May.
  • Handle: RePEc:sae:medema:v:40:y:2020:i:4:p:474-482
    DOI: 10.1177/0272989X20924007
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X20924007
    Download Restriction: no

    File URL: https://libkey.io/10.1177/0272989X20924007?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:40:y:2020:i:4:p:474-482. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.